TP53 and breast carcinoma: These results underpin that p53 and Δ40p53 may play different roles in modulating the levels of stem cell and EMT regulators in breast cancer cells and that high levels of Δ40p53 may promote pluripotency and stem cell maintenance but not de-differentiation.